CNM-Au8

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark CNM-Au8 was filed as Word mark on 05/22/2020 at the World Intellectual Property Organization.

Trademark Details Last update: September 2, 2022

Trademark form Word mark
File reference 1536362
Countries Australia Canada China em Israel Japan South Korea New Zealand Russia Singapore
Base trademark US No. 88715145, December 4, 2019
Application date May 22, 2020
Expiration date May 22, 2030

Trademark owner

Suite 325,
3165 East Millrock Drive
US

Trademark representatives

1830 S STREET NW WASHINGTON DC 20009 US

goods and services

05 Therapeutic pharmaceuticals for the treatment of remyelination, diseases of multiple sclerosis, ALS and Parkinson's disease

Trademark history

Date Document number Area Entry
September 1, 2022 2022/35 Gaz AU RAW: Rule 18ter(2)(i) GP following a provisional refusal
January 26, 2022 2022/7 Gaz CA Rejection
January 17, 2022 2022/3 Gaz RU Rejection
August 5, 2021 2021/32 Gaz KR Rejection
July 1, 2021 2021/26 Gaz JP Rejection
June 28, 2021 2021/26 Gaz RU Rejection
March 3, 2021 2021/9 Gaz Correction
March 2, 2021 2021/9 Gaz NZ Rejection
January 9, 2021 2021/2 Gaz IL Rejection
December 26, 2020 2020/53 Gaz SG Rejection
November 4, 2020 2020/45 Gaz EM Rejection
October 12, 2020 2020/42 Gaz CN Rejection
September 25, 2020 2020/40 Gaz AU Rejection
May 22, 2020 2020/23 Gaz US Registration

ID: 141536362